CPRA >98% form for highly sensitized candidates removed
All candidates with a CPRA above 98% continue to be prioritized on the match appropriately.
All candidates with a CPRA above 98% continue to be prioritized on the match appropriately.
Transplant hospitals will no longer be required to obtain signatures and update candidate registrations when a candidate’s CPRA is above 98%. There are no changes needed for OPOs.
Patient care will not be impacted during this time.
Twenty-two UNOS staff members presented research from 42 studies at the 2023 American Transplant Congress, addressing topics including social determinants of health, offer-acceptance practices, and the impacts of allocation-policy changes.
These changes were approved by the OPTN Board of Directors at their June 26, 2023 meeting.
The OPTN is offering 14 items for review.